Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Evaluation of the Protective Efficacy of a Vaccine Derived From the Synthetic CS Protein of Plasmodium Vivax

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02083068
Recruitment Status : Completed
First Posted : March 11, 2014
Last Update Posted : March 23, 2018
The Administrative Department of Science, Technology and Innovation, Colciencias
Information provided by (Responsible Party):
Socrates Herrera Valencia, Malaria Vaccine and Drug Development Center